Latest Updates

Alembic gains final USFDA approval for Albendazole Tablets USP, 200 mg

Read more

Parexel strengthens real world research offering

Read more

Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Read more

NATCO Canada announces $ 8 mn investment in eGenesis

Read more

Lupin launches Mirabegron Extended-Release Tablets in the US

Read more

STEER World appoints Dhiraj Tiwari as CFO

Read more

WHO’s mpox response aims to reduce disease burden, provides scope for developers

Read more

ENTOD’s PresVu eye drops gain DCGI approval

Read more

MK Hamied, Vice Chairman and Non-Executive Director, Cipla steps down

Read more

Making sustainability sustainable

Read more